Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

Background: Estimates of the association between COVID-19 vaccines and myo-/pericarditis risk vary widely across studies due to scarcity of events, especially in age- and sex-stratified analyses.Methods: Population-based cohort study with nested self-controlled risk interval (SCRI) using healthcare...

Full description

Bibliographic Details
Main Authors: Sophie H. Bots, Judit Riera-Arnau, Svetlana V. Belitser, Davide Messina, Maria Aragón, Ema Alsina, Ian J. Douglas, Carlos E. Durán, Patricia García-Poza, Rosa Gini, Ron M. C. Herings, Consuelo Huerta, Malede Mequanent Sisay, Mar Martín-Pérez, Ivonne Martin, Jetty A. Overbeek, Olga Paoletti, Meritxell Pallejà-Millán, Anna Schultze, Patrick Souverein, Karin M. A. Swart, Felipe Villalobos, Olaf H. Klungel, Miriam C. J. M. Sturkenboom
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Pharmacology
Subjects:
myocarditis
pericarditis
COVID-19 vaccine
adverse drug reaction
pharmacovigilance
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1038043/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.1038043/full

Similar Items